{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:31:00Z","timestamp":1781706660533,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":71,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.vaccine.2022.06.038","type":"journal-article","created":{"date-parts":[[2022,6,28]],"date-time":"2022-06-28T21:01:40Z","timestamp":1656450100000},"page":"4772-4779","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vaccines against Neisseria meningitidis serogroup B strains \u2013 What does genomics reveal on the Portuguese strain\u2019s coverage"],"prefix":"10.1016","volume":"40","author":[{"given":"C\u00e9lia","family":"Bettencourt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8316-5035","authenticated-orcid":false,"given":"Paulo","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Paulo Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Jo\u00e3o Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12 SUPPL.","key":"10.1016\/j.vaccine.2022.06.038_b0005","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.inf.0000147642.85129.05","article-title":"Global epidemiology of meningococcal disease and vaccine efficacy","volume":"23","author":"Pollard","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.038_b0010","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3201\/eid1904.111799","article-title":"Description and nomenclature of Neisseria meningitidis capsule locus","volume":"19","author":"Harrison","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.038_b0015","unstructured":"European Center for Disease Control and Prevention. Surveillance Atlas of Infectious Diseases. https:\/\/atlas.ecdc.europa.eu\/public\/index.aspx?Dataset=27&HealthTopic=36. [accessed 23\u201305-21]."},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2022.06.038_b0020","doi-asserted-by":"crossref","first-page":"B42","DOI":"10.1016\/j.vaccine.2009.05.001","article-title":"Meningococcal protein antigens and vaccines","volume":"27","author":"Feavers","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.06.038_b0025","article-title":"The development of a vaccine against Meningococcus B using reverse vaccinology","volume":"10","author":"Masignani","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2022.06.038_b0030","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/600141","article-title":"Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis","volume":"200","author":"Murphy","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.038_b0035","unstructured":"European Medicines Agency recommends approval of the first vaccine for meningitis https:\/\/www.ema.europa.eu\/en\/documents\/press-release\/european-medicines-agency recommends-approval-first-vaccine-meningitis-b_en.pdf [accessed 23-05-21]."},{"key":"10.1016\/j.vaccine.2022.06.038_b0040","unstructured":"Trumenba_H_C_4051_II_0013: EPAR_Assessment Report https:\/\/www.ema.europa.eu\/en\/documents\/assessment-report\/trumenba-epar-public-assessment-report_en.pdf. [accessed 23-05-21]."},{"issue":"47","key":"10.1016\/j.vaccine.2022.06.038_b0045","doi-asserted-by":"crossref","first-page":"7542","DOI":"10.1016\/j.vaccine.2020.09.050","article-title":"Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates","volume":"38","author":"Biolchi","year":"2020","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2022.06.038_b0050","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment","volume":"13","author":"Vogel","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.038_b0055","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.vaccine.2013.03.063","article-title":"Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB)","volume":"32","author":"Bettinger","year":"2013","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.vaccine.2022.06.038_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.04.015","article-title":"Global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine","volume":"33","author":"Medini","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2022.06.038_b0065","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00261-17","article-title":"Meningococcal antigen typing system (MATS)-based \u00d1eisseria meningitidis serogroup B coverage prediction for the MenB-4C vaccine in the united states","volume":"2","author":"Rajam","year":"2017","journal-title":"mSphere"},{"issue":"9","key":"10.1016\/j.vaccine.2022.06.038_b0070","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1080\/21645515.2021.1904758","article-title":"High coverage of diverse invasive meningococcal serogroup B strains by the 4-component vaccine 4CMenB in Australia, 2007\u20132011: Concordant predictions between MATS and genetic MATS","volume":"17","author":"Tozer","year":"2021","journal-title":"Human Vaccines & Immunother"},{"issue":"7","key":"10.1016\/j.vaccine.2022.06.038_b0075","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.vaccine.2018.12.061","article-title":"Genetic meningococcal antigen typing system (gMATS): a genotyping tool that predicts 4CMenB strain coverage worldwide","volume":"37","author":"Muzzi","year":"2019","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2022.06.038_b0080","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1073\/pnas.1013758107","article-title":"Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines","volume":"107","author":"Donnelly","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.038_b0085","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00036-18","article-title":"Predicting the susceptibility of meningococcal serogroup B isolates to bactericidal antibodies elicited by bivalent rLP2086, a novel prophylactic vaccine","volume":"9","author":"McNeil","year":"2018","journal-title":"MBio"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.038_b0090","first-page":"1","article-title":"Meningococcal deduced vaccine antigen reactivity (MenDeVAR) index: a rapid and accessible tool that exploits genomic data in public health and clinical microbiology applications","volume":"59","author":"Rodrigues","year":"2021","journal-title":"J Clin Microbiol"},{"issue":"24","key":"10.1016\/j.vaccine.2022.06.038_b0095","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1016\/j.vaccine.2006.03.091","article-title":"Neisseria meningitidis group B correlates of protection and assay standardization\u2014international meeting report emory university, atlanta, georgia, United States, 16\u201317 March 2005","volume":"24","author":"Borrow","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2022.06.038_b0100","unstructured":"Minist\u00e9rio da Sa\u00fade. Dire\u00e7\u00e3o-Geral da Sa\u00fade. Programa Nacional de Vacina\u00e7\u00e3o 2020. Lisboa: DGS, 2020.https:\/\/www.dgs.pt\/normas-orientacoes-e-informacoes\/normas-e-circulares-normativas\/norma-n-0182020-de-27092020-pdf.aspx. [accessed 23-05-21]."},{"key":"10.1016\/j.vaccine.2022.06.038_b0105","unstructured":"Comiss\u00e3o de Vacinas da Sociedade de Infeciologia Pedi\u00e1trica e da Sociedade Portuguesa de Pediatria Janeiro2018. http:\/\/criancaefamilia.spp.pt\/media\/127910\/Vacinas-extra-PNV-RecomendaCOes-SIP-SPP-2018.pdf. [accessed 23-05-21]."},{"key":"10.1016\/j.vaccine.2022.06.038_b0110","unstructured":"World Health Organization. Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumonia and Haemophilus influenzae. WHO manual, 2nd Edition. World Health Organ. Published online 2011. http:\/\/www.cdc.gov\/meningitis\/lab-manual\/. [accessed 23-05-21]."},{"key":"10.1016\/j.vaccine.2022.06.038_b0115","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-11-595","article-title":"BIGSdb: scalable analysis of bacterial genome variation at the population level","volume":"11","author":"Jolley","year":"2010","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.vaccine.2022.06.038_b0120","unstructured":"R Core Team (2021). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Published online 2021. https:\/\/www.R-project.org\/. [accessed 20-08-21]."},{"key":"10.1016\/j.vaccine.2022.06.038_b0125","unstructured":"RStudio Team. (2020). RStudio: Integrated Development for R. RStudio, PBC, Boston, MA. Published online 2020. http:\/\/www.rstudio.com\/. [accessed 20-08-21]."},{"issue":"28","key":"10.1016\/j.vaccine.2022.06.038_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2020.04.074","article-title":"High genomic-based predicted strain coverage among invasive meningococcal isolates when combining Bexsero and Trumenba vaccines","volume":"38","author":"S\u00e4ll","year":"2020","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2022.06.038_b0135","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/vaccines8030469","article-title":"Effectiveness and impact of the 4CMenB vaccine against group B meningococcal disease in two Italian regions using different vaccination schedules: a five-year retrospective observational study (2014\u20132018)","volume":"8","author":"Azzari","year":"2020","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.038_b0140","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jinf.2021.01.030","article-title":"Molecular characterization of invasive serogroup B Neisseria meningitidis isolates from Spain during 2015\u20132018: evolution of the vaccine antigen factor H binding protein (FHbp)","volume":"82","author":"Abad","year":"2021","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2022.06.038_b0145","doi-asserted-by":"crossref","first-page":"e0176177","DOI":"10.1371\/journal.pone.0176177","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Portugal","volume":"12","author":"Sim\u00f5es","year":"2017","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.038_b0150","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1128\/CVI.00669-14","article-title":"A large portion of meningococcal antigen typing system-negative meningococcal strains from Spain is killed by sera from adolescents and infants immunized with 4CMenB","volume":"22","author":"Abad","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"43","key":"10.1016\/j.vaccine.2022.06.038_b0155","doi-asserted-by":"crossref","first-page":"4968","DOI":"10.1016\/j.vaccine.2013.08.006","article-title":"Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage","volume":"31","author":"Frosi","year":"2013","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2022.06.038_b0160","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.20449","article-title":"Association of use of a meningococcus group B vaccine with Group B invasive meningococcal disease among children in Portugal. JAMA -","volume":"324","author":"Rodrigues","year":"2020","journal-title":"J Am Med Assoc"},{"issue":"10061","key":"10.1016\/j.vaccine.2022.06.038_b0165","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/S0140-6736(16)31921-3","article-title":"Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study","volume":"388","author":"Parikh","year":"2016","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2022.06.038_b0170","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1056\/NEJMoa1901229","article-title":"Vaccination of Infants with meningococcal group B Vaccine (4CMenB) in England","volume":"382","author":"Ladhani","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.06.038_b0175","unstructured":"RECOMENDA\u00c7\u00d5ES SOBRE VACINAS: ACTUALIZA\u00c7\u00c3O 2014 Comiss\u00e3o de Vacinas da Sociedade de Infeciologia Pedi\u00e1trica (SIP) e Sociedade Portuguesa de Pediatria (SPP). http:\/\/www.spp.pt\/UserFiles\/file\/Comissao_de_Vacinas\/RECOMENDACOES_SOBRE_VACINAS_EXTRA_PNV_2014%20_1_%20FINAL.pdf."},{"issue":"3","key":"10.1016\/j.vaccine.2022.06.038_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9030519","article-title":"A narrative review of the W, X, Y, E, and Ng of meningococcal disease: emerging capsular groups, pathotypes, and global control","volume":"9","author":"Tzeng","year":"2021","journal-title":"Microorganisms"},{"issue":"7","key":"10.1016\/j.vaccine.2022.06.038_b0185","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa1244","article-title":"First real-world evidence of meningococcal group B vaccine, 4CMenB, protection against meningococcal group W disease: prospective enhanced national surveillance, england","volume":"73","author":"Ladhani","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2022.06.038_b0190","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1128\/CVI.00090-13","article-title":"Genetic distribution of noncapsular meningococcal group B vaccine antigens in Neisseria lactamica","volume":"20","author":"Lucidarme","year":"2013","journal-title":"Clin Vaccine Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2022.06.038_b0195","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy1061","article-title":"The serogroup B meningococcal vaccine Bexsero elicits antibodies to Neisseria gonorrhoeae","volume":"69","author":"Semchenko","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"10102","key":"10.1016\/j.vaccine.2022.06.038_b0200","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(17)31449-6","article-title":"Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study","volume":"390","author":"Petousis-Harris","year":"2017","journal-title":"Lancet"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22008076?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22008076?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:17:52Z","timestamp":1759403872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22008076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":40,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0264410X22008076"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccines against Neisseria meningitidis serogroup B strains \u2013 What does genomics reveal on the Portuguese strain\u2019s coverage","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}